These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

522 related items for PubMed ID: 16481906

  • 1. The efficacy of gadobenate dimeglumine (Gd-BOPTA) at 3 Tesla in brain magnetic resonance imaging: comparison to 1.5 Tesla and a standard gadolinium chelate using a rat brain tumor model.
    Runge VM, Biswas J, Wintersperger BJ, Baumann SS, Jackson CB, Herborn CU, Patel T.
    Invest Radiol; 2006 Mar; 41(3):244-8. PubMed ID: 16481906
    [Abstract] [Full Text] [Related]

  • 2. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
    Fries P, Runge VM, Bücker A, Schürholz H, Reith W, Robert P, Jackson C, Lanz T, Schneider G.
    Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
    [Abstract] [Full Text] [Related]

  • 3. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
    Liang J, Sammet S, Yang X, Jia G, Takayama Y, Knopp MV.
    Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
    [Abstract] [Full Text] [Related]

  • 4. Low-dose contrast-enhanced magnetic resonance imaging of brain metastases at 3.0 T using high-relaxivity contrast agents.
    Huang B, Liang CH, Liu HJ, Wang GY, Zhang SX.
    Acta Radiol; 2010 Feb; 51(1):78-84. PubMed ID: 19912078
    [Abstract] [Full Text] [Related]

  • 5. Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine.
    Bauner KU, Reiser MF, Huber AM.
    Invest Radiol; 2009 Feb; 44(2):95-104. PubMed ID: 19077911
    [Abstract] [Full Text] [Related]

  • 6. Relaxivity of Gadopentetate Dimeglumine (Magnevist), Gadobutrol (Gadovist), and Gadobenate Dimeglumine (MultiHance) in human blood plasma at 0.2, 1.5, and 3 Tesla.
    Pintaske J, Martirosian P, Graf H, Erb G, Lodemann KP, Claussen CD, Schick F.
    Invest Radiol; 2006 Mar; 41(3):213-21. PubMed ID: 16481903
    [Abstract] [Full Text] [Related]

  • 7. Brain tumor enhancement in magnetic resonance imaging: dependency on the level of protein binding of applied contrast agents.
    Wintersperger BJ, Runge VM, Tweedle MF, Jackson CB, Reiser MF.
    Invest Radiol; 2009 Feb; 44(2):89-94. PubMed ID: 19077910
    [Abstract] [Full Text] [Related]

  • 8. Intra-individual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for contrast-enhanced magnetic resonance angiography of the supraaortic vessels at 3 Tesla.
    Bueltmann E, Erb G, Kirchin MA, Klose U, Naegele T.
    Invest Radiol; 2008 Oct; 43(10):695-702. PubMed ID: 18791411
    [Abstract] [Full Text] [Related]

  • 9. Focal liver lesions: whether a standard dose (0.05 mmol/kg) gadobenate dimeglumine can provide the same diagnostic data as the 0.1 mmol/kg dose.
    Nural MS, Gokce E, Danaci M, Bayrak IK, Diren HB.
    Eur J Radiol; 2008 Apr; 66(1):65-74. PubMed ID: 17555901
    [Abstract] [Full Text] [Related]

  • 10. Brain tumor enhancement in MR imaging at 3 Tesla: comparison of SNR and CNR gain using TSE and GRE techniques.
    Wintersperger BJ, Runge VM, Biswas J, Reiser MF, Schoenberg SO.
    Invest Radiol; 2007 Aug; 42(8):558-63. PubMed ID: 17620938
    [Abstract] [Full Text] [Related]

  • 11. Low-dose gadobenate dimeglumine versus standard-dose gadopentate dimeglumine for delayed contrast-enhanced cardiac magnetic resonance imaging.
    Balci NC, Inan N, Anik Y, Erturk MS, Ural D, Demirci A.
    Acad Radiol; 2006 Jul; 13(7):833-9. PubMed ID: 16777557
    [Abstract] [Full Text] [Related]

  • 12. Gadobenate dimeglumine (Gd-DTPA) vs gadopentetate dimeglumine (Gd-BOPTA) for contrast-enhanced magnetic resonance angiography (MRA): improvement in intravascular signal intensity and contrast to noise ratio.
    Pediconi F, Fraioli F, Catalano C, Napoli A, Danti M, Francone M, Venditti F, Nardis P, Passariello R.
    Radiol Med; 2003 Jul; 106(1-2):87-93. PubMed ID: 12951555
    [Abstract] [Full Text] [Related]

  • 13. Magnetic resonance coronary angiography: comparison between a Gd-BOPTA- and a Gd-DTPA-enhanced spoiled gradient-echo sequence and a non-contrast-enhanced steady-state free-precession sequence.
    Nassenstein K, Breuckmann F, Hunold P, Barkhausen J, Schlosser T.
    Acta Radiol; 2009 May; 50(4):406-11. PubMed ID: 19308763
    [Abstract] [Full Text] [Related]

  • 14. Primary and secondary brain tumors at MR imaging: bicentric intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine.
    Knopp MV, Runge VM, Essig M, Hartman M, Jansen O, Kirchin MA, Moeller A, Seeberg AH, Lodemann KP.
    Radiology; 2004 Jan; 230(1):55-64. PubMed ID: 14695387
    [Abstract] [Full Text] [Related]

  • 15. Enhancing lesions of the brain: intraindividual crossover comparison of contrast enhancement after gadobenate dimeglumine versus established gadolinium comparators.
    Essig M, Tartaro A, Tartaglione T, Pirovano G, Kirchin MA, Spinazzi A.
    Acad Radiol; 2006 Jun; 13(6):744-51. PubMed ID: 16679277
    [Abstract] [Full Text] [Related]

  • 16. Kinetics of gadobenate dimeglumine in isolated perfused rat liver: MR imaging evaluation.
    Pastor CM, Planchamp C, Pochon S, Lorusso V, Montet X, Mayer J, Terrier F, Vallee JP.
    Radiology; 2003 Oct; 229(1):119-25. PubMed ID: 12944603
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of gadoxetate disodium as a contrast agent for mouse liver imaging: comparison with gadobenate dimeglumine.
    Kiryu S, Inoue Y, Watanabe M, Izawa K, Shimada M, Tojo A, Yoshikawa K, Ohtomo K.
    Magn Reson Imaging; 2009 Jan; 27(1):101-7. PubMed ID: 18599243
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In vivo gadolinium neutron capture therapy using a potentially effective compound (Gd-BOPTA).
    Matsumura A, Zhang T, Yamamoto T, Yoshida F, Sakurai Y, Shimojo N, Nose T.
    Anticancer Res; 2003 Jan; 23(3B):2451-6. PubMed ID: 12894527
    [Abstract] [Full Text] [Related]

  • 20. Pulse repetition time and contrast enhancement: simulation study of Gd-BOPTA and conventional contrast agent at different field strengths.
    Yrjänä SK, Vaara T, Karttunen A, Koivukangas J.
    Invest Radiol; 2008 Apr; 43(4):267-75. PubMed ID: 18340251
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.